September 27, 2015
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed.
Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
July 27, 2015
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim. Unlike previous FDA clearances for Propeller, the new clearances actually allow Propeller to market its new devices as improving — not just...
March 31, 2015
LifeMap Solutions, the San Jose, California-based company that recently collaborated with Apple on one of the flagship apps for Apple ResearchKit, has launched a new pilot with Mount Sinai Hospital in New York. LifeMap will team up with Mount Sinai's Icahn School of Medicine and the National Jewish Health Respiratory Institute (NJHRI) to develop a COPD platform that includes both a mobile app and...
March 3, 2015
Chrono Therapeutics, a Hayward, California-based company working on a new wearable for smoking cessation and drug delivery, has received an investment from seed fund Rock Health. According to MedCity News, Rock Health has contributed $100,000. This brings the company's total funding to about $32.1 million.
Chrono disclosed its most recent round in June 2014. It included contributions from Canaan...
February 24, 2015
A Memotext intervention for diabetes.
A new text messaging software aimed at improving medication adherence will be offered to asthma patients who are members of AmeriHealth District of Columbia, Washington, D.C.'s largest Medicaid managed care organization. The platform, called HealthNHand, was developed by Memotext and will be launched by pharmacy benefit management company PerformRx....
January 13, 2015
Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000. That's a 54 percent increase in the mean total number of prescription fills per patient.
November 11, 2014
Pleasanton, California-based Spirometrix, a company working on a breath analysis sensor for early detection and treatment of asthma and COPD, has raised $8.6 million in second round funding. The round was led by NGK Spark Plugs, a Japanese company that manufactures spark plugs and oxygen sensors, which contributed $5 million. Existing investor Simul Investments also contributed. The raise brings...
October 8, 2014
CoheroHealth, a New York City-based startup working on medication adherence tracking for asthma inhalers, is launching a small pilot with Mount Sinai Medical Center. The company will test its platform, which includes an inhaler sensor, a mobile app, and a connected spirometer, on 50 pediatric asthma patients.
"There are 50 million patients with respiratory disease and it costs $80 billion per...
September 30, 2014
Boehringer Ingelheim is a pretty familiar name to people who follow mobile health moves from pharma companies. The large, privately-owned German firm has been involved in pilots with game developer Ayogo, smart pill bottle maker AdhereTech, and now-defunct behavior change platform Healthrageous.
While its partners have talked up these pilots, up until now the company itself has been pretty quiet...